These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 8692821

  • 21. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG.
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [Abstract] [Full Text] [Related]

  • 22. Autoantibodies to IA-2 in IDDM: location of major antigenic determinants.
    Zhang B, Lan MS, Notkins AL.
    Diabetes; 1997 Jan; 46(1):40-3. PubMed ID: 8971079
    [Abstract] [Full Text] [Related]

  • 23. ICA512 autoantibody radioassay.
    Gianani R, Rabin DU, Verge CF, Yu L, Babu SR, Pietropaolo M, Eisenbarth GS.
    Diabetes; 1995 Nov; 44(11):1340-4. PubMed ID: 7589834
    [Abstract] [Full Text] [Related]

  • 24. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
    Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E.
    J Immunol; 1996 Sep 15; 157(6):2707-11. PubMed ID: 8805677
    [Abstract] [Full Text] [Related]

  • 25. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E, Lampasona V, Bingley PJ.
    J Immunol; 1998 Sep 01; 161(5):2648-54. PubMed ID: 9725268
    [Abstract] [Full Text] [Related]

  • 26. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S, Willis J, Maclean C, Ananieva-Jordanova R, Amoroso MA, Brooking H, Powell M, Collins A, Bennett S, Mitchell S, Burne P, Furmaniak J, Smith BR.
    Clin Chim Acta; 2005 Jul 01; 357(1):74-83. PubMed ID: 15963796
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.
    Hawkes CJ, Wasmeier C, Christie MR, Hutton JC.
    Diabetes; 1996 Sep 01; 45(9):1187-92. PubMed ID: 8772720
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM.
    Feeney SJ, Myers MA, Mackay IR, Zimmet PZ, Howard N, Verge CF, Rowley MJ.
    Diabetes Care; 1997 Sep 01; 20(9):1403-7. PubMed ID: 9283787
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells.
    Xie H, Deng YJ, Notkins AL, Lan MS.
    Clin Exp Immunol; 1998 Sep 01; 113(3):367-72. PubMed ID: 9737664
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.